alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial

A.M. Woltman; M.K. Borg; R.S. Binda; D. Sprengers; B.M.E. von Blomberg-van der Flier; R.J. Scheper; K. Hayashi; N. Nishi; A. Boonstra; R. von der Molen; H.L.A. Janssen

doi:10.3851/IMP1295

alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial

A.M. Woltman, M.K. Borg, R.S. Binda, D. Sprengers, B.M.E. von Blomberg-van der Flier, R.J. Scheper, K. Hayashi, N. Nishi, A. Boonstra, R. von der Molen, H.L.A. Janssen

Pathology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	809-818
Journal	Antiviral Therapy
Volume	14
Issue number	6
DOIs	https://doi.org/10.3851/IMP1295
Publication status	Published - 2009

Access to Document

10.3851/IMP1295

Cite this

Woltman, A. M., Borg, M. K., Binda, R. S., Sprengers, D., von Blomberg-van der Flier, B. M. E., Scheper, R. J., Hayashi, K., Nishi, N., Boonstra, A., von der Molen, R., & Janssen, H. L. A. (2009). alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antiviral Therapy, 14(6), 809-818. https://doi.org/10.3851/IMP1295

@article{8b06cef6b6cc49acbcdfbfd41fbe13c7,

title = "alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial",

author = "A.M. Woltman and M.K. Borg and R.S. Binda and D. Sprengers and {von Blomberg-van der Flier}, B.M.E. and R.J. Scheper and K. Hayashi and N. Nishi and A. Boonstra and {von der Molen}, R. and H.L.A. Janssen",

year = "2009",

doi = "10.3851/IMP1295",

language = "Undefined/Unknown",

volume = "14",

pages = "809--818",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "International Medical Press Ltd",

number = "6",

}

Woltman, AM, Borg, MK, Binda, RS, Sprengers, D, von Blomberg-van der Flier, BME, Scheper, RJ, Hayashi, K, Nishi, N, Boonstra, A, von der Molen, R & Janssen, HLA 2009, 'alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial', Antiviral Therapy, vol. 14, no. 6, pp. 809-818. https://doi.org/10.3851/IMP1295

TY - JOUR

T1 - alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial

AU - Woltman, A.M.

AU - Borg, M.K.

AU - Binda, R.S.

AU - Sprengers, D.

AU - von Blomberg-van der Flier, B.M.E.

AU - Scheper, R.J.

AU - Hayashi, K.

AU - Nishi, N.

AU - Boonstra, A.

AU - von der Molen, R.

AU - Janssen, H.L.A.

PY - 2009

Y1 - 2009

U2 - 10.3851/IMP1295

DO - 10.3851/IMP1295

M3 - Article

C2 - 19812443

VL - 14

SP - 809

EP - 818

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 6

ER -